Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others... Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. Show more
Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer PR Newswire LEXINGTON, Mass., Sept. 23, 2024 Symposium hosted by Eric S. Winer, MD, and Grzegorz S. Nowakowski, MD Updated data for 10...
Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference PR Newswire LEXINGTON, Mass., Sept. 17, 2024 LEXINGTON, Mass., Sept. 17, 2024 /PRNewswire/ -- Curis, Inc...
Curis to Present at Upcoming Healthcare Conferences in September PR Newswire LEXINGTON, Mass., Sept. 4, 2024 LEXINGTON, Mass., Sept. 4, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a...
Curis Provides Second Quarter 2024 Financial and Operating Update PR Newswire LEXINGTON, Mass., Aug. 1, 2024 EC Grants ODD to emavusertib in PCNSL Management to host conference call and webcast...
Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024 PR Newswire LEXINGTON, Mass., July 25, 2024 LEXINGTON, Mass., July 25...
Curis to Present at Upcoming Healthcare Conference in July PR Newswire LEXINGTON, Mass., July 10, 2024 LEXINGTON, Mass., July 10, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology...
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire LEXINGTON, Mass., July 8, 2024 LEXINGTON, Mass., July 8, 2024 /PRNewswire/ --Β Curis, Inc. (NASDAQ: CRIS), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0575 | -1.12085769981 | 5.13 | 5.54 | 5 | 28850 | 5.21226849 | CS |
4 | -0.1275 | -2.45192307692 | 5.2 | 6.44 | 4.765 | 34161 | 5.51609858 | CS |
12 | -1.8975 | -27.2238163558 | 6.97 | 8.29 | 4.0516 | 47287 | 5.68627417 | CS |
26 | -8.3375 | -62.1737509321 | 13.41 | 17.49 | 4.0516 | 38919 | 8.22280051 | CS |
52 | -0.2275 | -4.29245283019 | 5.3 | 17.49 | 3.8 | 49997 | 9.06466946 | CS |
156 | -152.3275 | -96.7773189327 | 157.4 | 164 | 3.8 | 1014793 | 39.91217531 | CS |
260 | -38.5275 | -88.3658256881 | 43.6 | 348 | 3.8 | 1632365 | 99.85084544 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.